Hormone therapy use and young-onset breast cancer: a pooled analysis of prospective cohorts included in the Premenopausal Breast Cancer Collaborative Group

Katie M. O’Brien(National Institutes of Health), Dale P. Sandler(University of North Carolina at Chapel Hill), Alpa V. Patel(American Cancer Society), Fergus J. Couch(Mayo Clinic), Graham G. Giles(The University of Melbourne), Jessica Clague DeHart(Claremont Graduate University), William J. Blot(Shanghai Cancer Institute), Michael E. Jones(Institute of Cancer Research), Victoria A. Kirsh(St. Elizabeth's Hospital), Lauren R. Teras(American Cancer Society), Celine M Vachon(Mayo Clinic in Florida), Cari M. Kitahara(National Institutes of Health), Roger L. Milne(The University of Melbourne), Hazel B. Nichols(University of North Carolina at Chapel Hill), Amy Berrington de González(Institute of Cancer Research), Thomas E. Rohan(Albert Einstein College of Medicine), Kimberly A. Bertrand(Université Paris-Sud), Montserrat García‐Closas(Institute of Cancer Research), Jian‐Min Yuan(University of Pittsburgh), Hannah Lui Park(University of California, Irvine), Julie R. Palmer(Boston University), Wei Zheng(Vanderbilt University), Anthony J Swerdlow(Breast Cancer Now), Woon‐Puay Koh(Agency for Science, Technology and Research), Kala Visvanathan(Johns Hopkins University), Melissa G House(Westat (United States)), Minouk J. Schoemaker(Institute of Cancer Research), Clarice R. Weinberg(National Institute of Environmental Health Sciences), Mandy Goldberg(National Institute of Environmental Health Sciences)
The Lancet Oncology
July 1, 2025
Cited by 12


Related Papers